JP2002145779A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002145779A5 JP2002145779A5 JP2000344315A JP2000344315A JP2002145779A5 JP 2002145779 A5 JP2002145779 A5 JP 2002145779A5 JP 2000344315 A JP2000344315 A JP 2000344315A JP 2000344315 A JP2000344315 A JP 2000344315A JP 2002145779 A5 JP2002145779 A5 JP 2002145779A5
- Authority
- JP
- Japan
- Prior art keywords
- vitamin
- weight
- composition
- glucosamines
- glycosaminoglycans
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 12
- 150000002302 glucosamines Chemical class 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 11
- 235000013343 vitamin Nutrition 0.000 claims description 10
- 239000011782 vitamin Substances 0.000 claims description 10
- 229940088594 vitamin Drugs 0.000 claims description 10
- 229930003231 vitamin Natural products 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- 208000006820 Arthralgia Diseases 0.000 claims description 9
- 150000003839 salts Chemical class 0.000 claims description 8
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 6
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 5
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 5
- 229920002567 Chondroitin Polymers 0.000 claims description 3
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 claims description 3
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 claims description 3
- 229960002442 glucosamine Drugs 0.000 claims description 3
- -1 glucosamine compound Chemical class 0.000 claims description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 claims description 2
- FEZWOUWWJOYMLT-DSRCUDDDSA-M cobalt;[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,1 Chemical compound [Co].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FEZWOUWWJOYMLT-DSRCUDDDSA-M 0.000 claims description 2
- 239000011691 vitamin B1 Substances 0.000 claims 4
- 235000010374 vitamin B1 Nutrition 0.000 claims 4
- 229930003451 Vitamin B1 Natural products 0.000 claims 3
- 229960003495 thiamine Drugs 0.000 claims 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 2
- 230000001225 therapeutic effect Effects 0.000 claims 2
- 229920002971 Heparan sulfate Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 2
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- PDMUULPVBYQBBK-UHFFFAOYSA-N 4-[(3-butoxy-4-methoxyphenyl)methyl]-2-imidazolidinone Chemical compound C1=C(OC)C(OCCCC)=CC(CC2NC(=O)NC2)=C1 PDMUULPVBYQBBK-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical class [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000045 Dermatan sulfate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical class C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical class [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical class [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 229920001284 acidic polysaccharide Polymers 0.000 description 1
- 150000004805 acidic polysaccharides Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Chemical class 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- 150000002301 glucosamine derivatives Chemical class 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Chemical class 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Chemical class 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000344315A JP2002145779A (ja) | 2000-11-10 | 2000-11-10 | 関節痛治療または予防用組成物 |
| US09/986,442 US20020099032A1 (en) | 2000-11-10 | 2001-11-08 | Preparations and method of producing the same |
| KR1020010069694A KR100861430B1 (ko) | 2000-11-10 | 2001-11-09 | 제제 및 그의 제조 방법 |
| CN01143682A CN1357328A (zh) | 2000-11-10 | 2001-11-10 | 制剂和生产该制剂的方法 |
| HK02108345.3A HK1046646A1 (zh) | 2000-11-10 | 2002-11-18 | 製劑和生產該製劑的方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000344315A JP2002145779A (ja) | 2000-11-10 | 2000-11-10 | 関節痛治療または予防用組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003316550A Division JP2004026846A (ja) | 2003-09-09 | 2003-09-09 | 関節痛治療または予防用組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002145779A JP2002145779A (ja) | 2002-05-22 |
| JP2002145779A5 true JP2002145779A5 (it) | 2004-09-24 |
Family
ID=18818531
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000344315A Withdrawn JP2002145779A (ja) | 2000-11-10 | 2000-11-10 | 関節痛治療または予防用組成物 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2002145779A (it) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005154281A (ja) * | 2003-11-20 | 2005-06-16 | Ominedo Yakuhin Kogyo Kk | 関節障害予防及び治療用医薬組成物 |
| JP2005232089A (ja) * | 2004-02-19 | 2005-09-02 | Aloe Seiyaku Kk | 骨量増加作用を有する機能性経口投与剤 |
| TWI354559B (en) * | 2004-12-27 | 2011-12-21 | Yaizu Suisankagaku Ind Co Ltd | Oral disintegrative n-acetylglucosamine tablet and |
| JP2007137842A (ja) * | 2005-11-21 | 2007-06-07 | Medicaraise Corp | 錠核部を外層部で包接した二層形状からなる有核錠 |
| JP5023546B2 (ja) * | 2006-04-28 | 2012-09-12 | ゼリア新薬工業株式会社 | 経口固形製剤 |
| JP4601595B2 (ja) * | 2006-09-28 | 2010-12-22 | 小林製薬株式会社 | 消炎鎮痛用経口医薬組成物 |
| JP5587543B2 (ja) * | 2008-02-06 | 2014-09-10 | サントリーホールディングス株式会社 | グルコサミンを含有する経口投与用固形製剤 |
| JP5329866B2 (ja) * | 2008-08-07 | 2013-10-30 | 武田薬品工業株式会社 | 医薬組成物及び関節障害の予防治療剤 |
| CN104125831A (zh) * | 2012-02-29 | 2014-10-29 | 老笃制药株式会社 | 固体组合物 |
| CN109942568A (zh) * | 2019-04-03 | 2019-06-28 | 赤峰制药股份有限公司 | 一种硝酸硫胺制备方法 |
-
2000
- 2000-11-10 JP JP2000344315A patent/JP2002145779A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1114774A1 (en) | Compositions comprising an aminosugar, chondroitin, and s- adenosylmethionine | |
| US4762715A (en) | Antiherpetically active lipstick and the use thereof for the treatment of disorders of the lips and other areas of the face casued by human herpes viruses | |
| JP2002145779A5 (it) | ||
| MXPA02011942A (es) | Composiciones, equipos y metodos para estimular beneficios definidos para la salud. | |
| WO1995014491A3 (en) | Metal-ion chelates with acidic saccharides and glycosaminoglycans | |
| KR950002783A (ko) | 양이온-착화된 폴리사카라이드 | |
| BR9915753A (pt) | Métodos para reduzir a adstringência de estanosos em composições de dentifrìcios | |
| FI2034956T4 (fi) | Matalan viskositeetin omaavia glykosaminoglykaaneja käsittäviä koostumuksia ja mainitun koostumuksen käyttö kroonisen kystiitin terapiassa | |
| CA2404083A1 (en) | Use of polyphosphate as a tooth erosion inhibitor in acidic compositions | |
| EP1078636A4 (en) | NOVEL PHARMACEUTICAL COMPOSITION FOR EMERGENCY TREATMENT AND ITS PREPARATION METHOD | |
| EP1561760A3 (en) | Low molecular weight heparin salt with thriethanolamine | |
| BR0315149A (pt) | Misturas de polissacarìdeos derivados de heparina, sua preparação e as composições farmacêuticas que as contêm | |
| BRPI0417750A (pt) | composto da fórmula; composição farmacêutica ou veterinária; uso do composto, e método para prevenção e tratamento na área de glicosaminoglicano (gag) miméticos | |
| JP2001527022A5 (it) | ||
| EP0704216A1 (en) | Gel-like pharmaceutical compositions containing chondroitin sulfate salts suitable for oral administration | |
| CN105899233B (zh) | 糖胺聚糖和环糊精的组合 | |
| CA2014390A1 (fr) | Compositions therapeutiques pour le traitement ou la prevention du ronflement | |
| RU98107850A (ru) | Противовоспалительное средство | |
| AU4429801A (en) | Pharmaceutical compositions including alginates | |
| UA42722C2 (uk) | Сульфіди, сульфоксиди або сульфони, або їх фармацевтично прийнятні солі і фармацевтична композиція, що їх містить | |
| MX2014009410A (es) | Sales de oro y plata de glicosaminoglicanos parcialmente despolimerizadas. | |
| EP1110550A3 (en) | Composition comprising ascorbic acid and pectin | |
| JP2002145780A5 (it) | ||
| CA2026036A1 (en) | Sulphated glycosamino glycuronan with antithrombotic activity | |
| RO115414B1 (ro) | Compoziţie farmaceutică, intranazală |